कंपनी का अवलोकन
111, Inc. (YI) operates as an integrated online and offline platform within the healthcare market of the People's Republic of China, facilitating connections between pharmaceutical companies and end-users through its B2C and B2B segments. The entity provides supply chain integration services that assist pharmaceutical firms in managing product distribution and logistics across its operational segments. This business model places the company squarely within the Healthcare sector, specifically the Medical Distribution industry, a critical niche that bridges manufacturing and consumer or institutional consumption. The company's scale is quantified by a market capitalization of $56.16M, annual revenue of $13.58B, and an employee base of 1238 individuals. These financial figures indicate that while the company generates substantial top-line volume typical of large-scale distribution networks, its market cap suggests a valuation that does not proportionally reflect its total revenue generation, potentially signaling market skepticism regarding profitability or future growth trajectories.
वित्तीय स्वास्थ्य
111, Inc. reported a trailing twelve-month revenue of $13.58B, yet this massive revenue figure contrasts sharply with a net income loss of $70,012,000 and an EBITDA of $3.98M. The significant disparity between the $13.58B revenue and the -$70.01M net income reveals a highly inefficient cost structure where operating expenses and cost of goods sold consume nearly the entire revenue stream, leaving minimal earnings before interest and taxes. The company generated a free cash flow of -$22,583,250, which indicates a negative financial flexibility where cash outflows for operations and capital expenditures exceed cash inflows from sales, limiting the ability to fund internal growth without external financing. Margin analysis shows a gross margin of 2.8%, an operating margin of -0.1%, and a profit margin of -0.5%, all of which indicate that the business operates at a loss at every stage of the value chain, from wholesale pricing to final net profitability. On the balance sheet, the company holds $493.62M in cash against $204.73M in debt, resulting in a debt-to-equity ratio of 93.56, which suggests a highly leveraged position relative to equity despite the cash buffer. The current ratio stands at 1.07, indicating that current assets barely cover current liabilities, which points to tight short-term liquidity that leaves little room for error in meeting immediate obligations. Return on Equity is -10.9% and Return on Assets is -0.2%, metrics that reveal management is currently destroying shareholder value and utilizing assets inefficiently to generate returns.
मूल्यांकन आकलन
The valuation metrics for 111, Inc. present a complex picture, with a trailing P/E ratio listed as N/A due to negative earnings, while the forward P/E is 46.29, implying that the market is pricing in significant future earnings recovery or restructuring. The price-to-book ratio is -0.57, which indicates that the company's market value is below its book value, a rare occurrence for operating companies that often suggests distressed assets or severe accounting adjustments. The price-to-sales ratio is 0.00, reflecting that the negative net income has mathematically zeroed out the traditional multiple, while the EV/EBITDA stands at 437.63, an exceptionally high multiple that suggests extreme valuation sensitivity or market uncertainty regarding future cash generation capabilities. The stock's trading range over the last 52 weeks spans from a low of $2.48 to a high of $11.17, placing the current market sentiment in a volatile zone between these extremes. The beta value of 0.70 indicates that the stock price exhibits lower volatility than the broader market, moving with less intensity than the overall index despite the underlying financial instability.
Growth & Income
Revenue growth year-over-year has declined by -16.7%, while earnings growth is N/A due to the company's negative net income, indicating that the business is contracting rather than expanding its top line. Since the company has negative earnings, the concept of earnings growth relative to revenue is not applicable in a traditional sense, as the firm is not generating profits to reinvest or distribute. Consequently, the company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning the firm retains all cash flow to address its operational deficits and debt obligations rather than returning capital to shareholders. The overall growth and income profile is characterized by significant revenue contraction, negative profitability across all margins, and an absence of dividend income, presenting a challenging financial landscape for income-focused or growth-oriented investment strategies.